Roles of Anthrax Toxin Receptor 2 in Anthrax Toxin Membrane Insertion and Pore Formation.

Toxins (Basel)

Department of Biological Sciences, Border Biomedical Research Center, University of Texas at El Paso, 500 West University Avenue, El Paso, TX 79968, USA.

Published: January 2016

Interaction between bacterial toxins and cellular surface receptors is an important component of the host-pathogen interaction. Anthrax toxin protective antigen (PA) binds to the cell surface receptor, enters the cell through receptor-mediated endocytosis, and forms a pore on the endosomal membrane that translocates toxin enzymes into the cytosol of the host cell. As the major receptor for anthrax toxin in vivo, anthrax toxin receptor 2 (ANTXR2) plays an essential role in anthrax toxin action by providing the toxin with a high-affinity binding anchor on the cell membrane and a path of entry into the host cell. ANTXR2 also acts as a molecular clamp by shifting the pH threshold of PA pore formation to a more acidic pH range, which prevents premature pore formation at neutral pH before the toxin reaches the designated intracellular location. Most recent studies have suggested that the disulfide bond in the immunoglobulin (Ig)-like domain of ANTXR2 plays an essential role in anthrax toxin action. Here we will review the roles of ANTXR2 in anthrax toxin action, with an emphasis on newly updated knowledge.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773787PMC
http://dx.doi.org/10.3390/toxins8020034DOI Listing

Publication Analysis

Top Keywords

anthrax toxin
32
pore formation
12
toxin action
12
toxin
11
toxin receptor
8
receptor anthrax
8
host cell
8
antxr2 plays
8
plays essential
8
essential role
8

Similar Publications

Comparing microbiological and molecular diagnostic tools for the surveillance of anthrax.

PLoS Negl Trop Dis

November 2024

Department of Veterinary Tropical Diseases, Faculty of Veterinary Science, University of Pretoria, Onderstepoort, South Africa.

The diagnosis of anthrax, a zoonotic disease caused by Bacillus anthracis can be complicated by detection of closely related species. Conventional diagnosis of anthrax involves microscopy, culture identification of bacterial colonies and molecular detection. Genetic markers used are often virulence gene targets such as B.

View Article and Find Full Text PDF

Hyaline fibromatosis syndrome is a rare, progressive and fatal autosomal recessive disorder characterised by multiple subcutaneous skin nodules, osteopenia, joint contractures, failure to thrive, diarrhoea and frequent infections. There is diffuse deposition of hyaline material in the skin, gastrointestinal tract, muscle and endocrine glands. The disease is often underdiagnosed since infants affected with the disease pass away early prior to establishing a final diagnosis.

View Article and Find Full Text PDF

causes anthrax through a combination of bacterial infection and toxemia. As a major virulence factor of , anthrax lethal toxin (LT) is a zinc-dependent metalloproteinase, exerting its cytotoxicity through proteolytic cleavage of the mitogen-activated protein kinase kinases, thereby shutting down the MAPK pathways. Anthrax lethal toxin induces host lethality mostly by targeting the cardiovascular system.

View Article and Find Full Text PDF

Repurposing FDA-approved disulfiram for targeted inhibition of diphtheria toxin and the binary protein toxins of and .

Front Pharmacol

September 2024

Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, Ulm, Germany.

Article Synopsis
  • Many bacteria release AB-type protein toxins that disrupt cell functions, causing illness; targeting these toxins could lead to new treatments.
  • The FDA-approved drug disulfiram (DSF), typically used for alcohol dependence, shows potential in protecting cells from various toxins at low concentrations.
  • DSF appears to inhibit the translocation of toxic A subunits into cells without significantly affecting toxin binding or activity.
View Article and Find Full Text PDF

Alpha-1 antitrypsin inhibits Clostridium botulinum C2 toxin, Corynebacterium diphtheriae diphtheria toxin and B. anthracis fusion toxin.

Sci Rep

September 2024

Institute of Experimental and Clinical Pharmacology, Toxicology and Pharmacology of Natural Products, Ulm University Medical Center, 89081, Ulm, Germany.

Article Synopsis
  • The bacterium Clostridium botulinum produces C2 toxin, which is a binary AB-toxin that disrupts the cytoskeleton of cells, leading to cell death.
  • C2 toxin consists of an active A-component (C2I) and a binding B-component (C2II), which together enter cells and mediate their toxic effects by ADP-ribosylating G-actin.
  • The serine-protease inhibitor α-antitrypsin (αAT) can inhibit the effects of C2 toxin and other toxins, suggesting its potential repurposing as a treatment for diseases caused by these toxins.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!